• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制核糖核酸酶A家族酶可防止血清中siRNA的降解及沉默活性丧失。

Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum.

作者信息

Haupenthal Jörg, Baehr Christina, Kiermayer Simone, Zeuzem Stefan, Piiper Albrecht

机构信息

Department of Internal Medicine II, University of Saarland, D-66421 Homburg/Saar, Germany.

出版信息

Biochem Pharmacol. 2006 Feb 28;71(5):702-10. doi: 10.1016/j.bcp.2005.11.015. Epub 2006 Jan 10.

DOI:10.1016/j.bcp.2005.11.015
PMID:16376306
Abstract

Small interfering RNAs (siRNA), RNA duplexes of approximately 21 nucleotides, offer a promising approach to specifically degrade RNAs in target cells by a process termed RNA interference. Insufficient in vivo-stability is a major problem of a systemic application of siRNAs in humans. The present study demonstrated that RNAse A-like RNAses degraded siRNAs in serum. The susceptibility of siRNAs towards degradation in serum was strongly enhanced by local clustering of A/Us within the siRNA sequence, i.e. regions showing low thermal stability, most notably at the ends of the molecule, and by 3'-overhanging bases. Importantly, inhibition of RNAse A family enzymes prevented the degradation and loss of silencing activity of siRNAs in serum. Furthermore, the degradation of siRNAs was considerably faster in human than in mouse serum, suggesting that the degradation of siRNAs by RNAse A family enzymes might be a more challenging problem in a future therapeutic application of siRNAs in humans than in mouse models. Together, the present study indicates that siRNAs are degraded by RNAse A family enzymes in serum and that the kinetics of their degradation in serum depends on their sequence. These findings might be of great importance for a possible future human therapeutic application of siRNAs.

摘要

小干扰RNA(siRNA)是一种约21个核苷酸的RNA双链体,它为通过一种称为RNA干扰的过程特异性降解靶细胞中的RNA提供了一种有前景的方法。体内稳定性不足是siRNA在人体中全身应用的一个主要问题。本研究表明,类似核糖核酸酶A的核糖核酸酶会在血清中降解siRNA。siRNA序列中A/U的局部聚集,即显示低热稳定性的区域,最显著的是在分子末端,以及3'端突出碱基,会大大增强siRNA在血清中被降解的敏感性。重要的是,抑制核糖核酸酶A家族酶可防止血清中siRNA的降解和沉默活性的丧失。此外,siRNA在人血清中的降解速度比在小鼠血清中快得多,这表明在未来siRNA用于人体治疗时,核糖核酸酶A家族酶对siRNA的降解可能比在小鼠模型中是一个更具挑战性的问题。总之,本研究表明siRNA在血清中被核糖核酸酶A家族酶降解,并且它们在血清中的降解动力学取决于其序列。这些发现可能对未来siRNA在人体治疗中的应用具有重要意义。

相似文献

1
Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum.抑制核糖核酸酶A家族酶可防止血清中siRNA的降解及沉默活性丧失。
Biochem Pharmacol. 2006 Feb 28;71(5):702-10. doi: 10.1016/j.bcp.2005.11.015. Epub 2006 Jan 10.
2
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.体内通过RNA干扰(RNAi)实现基因沉默:基于直接应用小干扰RNA(siRNA)的策略。
J Biotechnol. 2006 Jun 25;124(1):12-25. doi: 10.1016/j.jbiotec.2005.12.003. Epub 2006 Jan 18.
3
Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.Dicer底物小干扰RNA的合理设计及其体内外递送
Nat Protoc. 2006;1(2):508-17. doi: 10.1038/nprot.2006.72.
4
Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.小干扰RNA核酸酶稳定性对小干扰RNA介导的基因沉默的体外和体内动力学的影响。
Biotechnol Bioeng. 2007 Jul 1;97(4):909-21. doi: 10.1002/bit.21285.
5
A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.聚乙烯亚胺(PEI)的低分子量部分在新鲜或冻干复合物中对DNA和siRNA的转染效率有所提高。
J Control Release. 2006 May 15;112(2):257-70. doi: 10.1016/j.jconrel.2006.02.009. Epub 2006 Mar 6.
6
Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.使用“特异性”小干扰RNA实现基因表达沉默超出了特异性范畴——一项关于小干扰RNA脱靶效应起始阶段需考虑的关键参数的研究。
FEBS J. 2008 Jun;275(11):2738-53. doi: 10.1111/j.1742-4658.2008.06415.x. Epub 2008 Apr 16.
7
Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.小干扰RNA(siRNA)的竞争效力由引导链的5'端半序列决定。
Biochem Biophys Res Commun. 2008 Feb 29;367(1):78-83. doi: 10.1016/j.bbrc.2007.12.099. Epub 2007 Dec 27.
8
[Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].[通过酶促合成和化学合成的小干扰RNA沉默c-myc基因表达]
Mol Biol (Mosk). 2006 Nov-Dec;40(6):1037-46.
9
Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.利用基因工程双链RNA结合蛋白结构域进行细胞内小分子干扰RNA递送
J Gene Med. 2009 Sep;11(9):804-12. doi: 10.1002/jgm.1365.
10
Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.与可生物降解的聚L-精氨酸复合的透明质酸用于小干扰RNA的靶向递送。
J Gene Med. 2009 Sep;11(9):791-803. doi: 10.1002/jgm.1352.

引用本文的文献

1
LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis.LINC00162基因沉默通过调节MAPK信号通路和细胞凋亡增强索拉非尼敏感性并抑制甲状腺癌细胞进展。
Sci Rep. 2025 Aug 13;15(1):29726. doi: 10.1038/s41598-025-12805-x.
2
Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells.制定使用丝球体将寡核苷酸治疗剂高效、靶向递送至癌细胞的策略。
Int J Nanomedicine. 2025 Jun 23;20:8023-8039. doi: 10.2147/IJN.S519906. eCollection 2025.
3
Single-Molecular Dissection of Liquid-Liquid Phase Transitions.
单分子解析液-液相变。
J Am Chem Soc. 2023 Aug 9;145(31):17143-17150. doi: 10.1021/jacs.3c03812. Epub 2023 Jul 26.
4
A Combination Therapy Using Electrical Stimulation and Adaptive, Conductive Hydrogels Loaded with Self-Assembled Nanogels Incorporating Short Interfering RNA Promotes the Repair of Diabetic Chronic Wounds.电刺激和负载自组装纳米胶的自适应导电水凝胶联合治疗促进糖尿病慢性伤口的修复。
Adv Sci (Weinh). 2022 Oct;9(30):e2201425. doi: 10.1002/advs.202201425. Epub 2022 Sep 5.
5
Keeping up with the COVID's-Could siRNA-based antivirals be a part of the answer?紧跟新冠疫情——基于小干扰RNA的抗病毒药物会是解决方案的一部分吗?
Exploration (Beijing). 2022 Jul 14;2(6):20220012. doi: 10.1002/EXP.20220012.
6
Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer.载多柔比星和多药耐药靶向 siRNAs 的多功能纳米粒治疗化疗耐药性食管癌。
J Nanobiotechnology. 2022 Mar 28;20(1):166. doi: 10.1186/s12951-022-01377-x.
7
Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment.双 pH 响应和肿瘤靶向纳米颗粒介导的抗血管生成 siRNA 递送来治疗肿瘤。
Int J Nanomedicine. 2022 Mar 5;17:953-967. doi: 10.2147/IJN.S340926. eCollection 2022.
8
Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery.具有通过对流增强递送进行siRNA递送前景的两亲性阴离子低聚物稳定的磷酸钙纳米颗粒。
Pharmaceutics. 2022 Jan 29;14(2):326. doi: 10.3390/pharmaceutics14020326.
9
Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential.环状RNA的最新研究进展:生物合成、特性、功能及治疗潜力
Mol Ther Nucleic Acids. 2021 Jun 4;25:355-371. doi: 10.1016/j.omtn.2021.05.022. eCollection 2021 Sep 3.
10
Chimeric Flaviviral RNA-siRNA Molecules Resist Degradation by The Exoribonuclease Xrn1 and Trigger Gene Silencing in Mammalian Cells.嵌合黄病毒 RNA-siRNA 分子可抵抗外切核酸酶 Xrn1 的降解并在哺乳动物细胞中触发基因沉默。
Chembiochem. 2021 Nov 3;22(21):3099-3106. doi: 10.1002/cbic.202100434. Epub 2021 Sep 12.